Optimisation of chemotherapy in the era of immunotherapy
Eur Respir J
.
2018 Oct 25;52(4):1801698.
doi: 10.1183/13993003.01698-2018.
Print 2018 Oct.
Authors
René Boosman
1
,
Jacobus Sjaak Adrianus Burgers
2
Affiliations
1
Dept of Pharmacy and Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
2
Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
PMID:
30361267
DOI:
10.1183/13993003.01698-2018
No abstract available
Publication types
Editorial
Comment
MeSH terms
Carcinoma, Non-Small-Cell Lung*
Cohort Studies
Humans
Immunotherapy
Lung Neoplasms*
Pemetrexed
Substances
Pemetrexed